Giuseppe Lippi/LinkedIn
Mar 14, 2026, 12:59
Giuseppe Lippi: New Highlights on Key Aspects of Heparin Anticoagulant Therapy and Monitoring
Giuseppe Lippi, Professor at University of Verona, Dean at Faculty of Medicine and Surgery, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“Happy to share our new article on ‘Heparin Anticoagulant Therapy and Its Monitoring’.”
Title: Heparin Anticoagulant Therapy and Its Monitoring
Authors: Benjamin Reardon, Leonardo Pasalic, Giuseppe Lippi, Emmanuel J. Favaloro
Read the Full Article on Biomolecules
See more in the gallery.
Other posts featuring Giuseppe Lippi on Hemostasis Today.
-
Nov 5, 2026, 18:20Jessica Vega: How Listening to Patient Experience Reframes Warm Autoimmune Hemolytic Anemia Care
-
Nov 5, 2026, 18:15Paresh P Kulkarni: Frontiers in Immunology Launches Call for Papers on Innate Immune Mechanisms and Biomarkers in APS
-
Nov 5, 2026, 18:08Perrine Henry: Iliac Venous Thrombus Identified as Rare Cause of Hindlimb Lameness in Dog with Primary Erythrocytosis
-
Nov 5, 2026, 18:02Kellie Machlus: Bone Marrow Megakaryocytes Present Antigens and Regulate T Cells
-
Nov 5, 2026, 14:42Matteo Foschi: ASPERA-R Reveals the Challenges of Anticoagulation Resumption After Hemorrhagic Transformation
-
Nov 5, 2026, 14:30Khaled Musallam: Assessing the State of Thalassaemia and Sickle Cell Disease Care Across Europe
-
Nov 5, 2026, 14:17Joshua Muia: The Evolution of ADAMTS13 Research
-
Nov 5, 2026, 14:02Paulo Colimodio: Scientific Highlights from the XVII Argentine Congress of Hemostasis and Thrombosis
-
Nov 5, 2026, 13:52Emmanuel J Favaloro: STH Reports 2025 Impact Factor and Most Highly Cited Papers